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ABSTRACT 
This paper presents a novel optical concept for the read- 
out of a parallel, bead-based fluorescence immunoassay 
conducted on a lab-on-a-disk platform. The reusable 
part of thc modular setup comprises a detection unit 
featuring a single LED as light source, two emission- 
filters, and a color CCD-camera as standard components 
together with a spinning drive as actuation unit. The 
miniaturized lab-on-a-disk is devised as a disposable. In 
the read-out process of the parallel assay, beads are first 
identified by the color of incorporated quantum dots 
(QDs). Next, the reaction-specific fluorescence signal is 
quantified with FluoSpheres-labeled detection anti- 
bodies. To enable a fast and automated read-out, suit- 
able algorithms have been implemented in this work. 
Based on this concept, we successfully demonstrated a 
Hepatitis-A assay on our disk-based lab-on-a-chip. 
Keywords: FIA, parallel assays, beads, quantum dots, 
centrifugal microfluidics 
INTRODUCTION 
The miniaturization of devices for clinical diagnostics 
towards point-of-care applications 1s subject of numer- 
ous approaches. Typically, such “lab-on-a-chip’’ or 
“micro total analysis” systems (pTAS) feature a full 
process integration, a high reproducibility, reduced 
consumption of sample and reagents as well as short 
times-to-result, and ease of handling [ 11-[6]. Besides 
the development of the analytical chips which are pref- 
erably disposable, detection devices have been 
developed which basically comprise an actuation and a 
read-out unit [7][8]. 
To further advance towards a comprehensive picture of 
the patient’s health state, especially in the field of emer- 
gency diagnostics, the parallel determination of a set of 
relevant biochemical markers in a given sample would 
drastically accelerate the benefit of these pTAS. 
As a special type of “lab-on-a-chip” systems, a “lab-on- 
a-disk” [SI-[ 121 exploits centrihgal forces generated by 
a spinning drive to pump liquids. On its way radially 
outwards, the sample is processed [ 13][ 141 and finally 
reaches a detection chamber. While the spinning drive, 
as the actuation unit, is a robust and reusable “macro” 
component, the “micro”-parts are here reduced to their 
functional essence, i.e. passive microstructures which 
can be fabricated in a very economic fashion, e.g. by 
industrial scale micromachining techniques such as hot- 
embossing or injection molding. 
The implicit advantages of centrifugal microfluidics like 
its robustness and reproducibility together with its cost 
efficiency recommend this platform for point-of-care 
applications, especially in the field of emergency as 
well as clinical diagnostics [15]-[17]. 
In our approach, a set of fluorescence immunoassays 
(FIAs) is run on a lab-on-a-disk with the use of color- 
tagged beads. Prior to loading them into the disk, the 
beads are fhctionalized with the relevant capture anti- 
bodies. In the automated read-out of the assay results 
using an image processing software, each bead is local- 
ized and spectrally identified in a first “tag-color” CCD 
image. A second fluorescence picture acquires com- 
pound fluorescence intensity of each bead. 
QUANTUM-DOTS AS OPTICAL BEAD-TAG 
Quantum-dot (QD) crystallites excel with their broad- 
band excitation and their narrow-band luminescence. 
Their spectrum can be tuned by their diameter 
( ~ Q D  5 nm) during fabrication [ 18]-[20]. We use the 
large number of optically distinguishable QDs made of 
CdSe for bead identification in parallel assays (Fig. 1). 
To this end, the QDs are first suspended with poly- 
styrene (PS) beads (abead = 150 pm) in an organic sol- 
vent. The solvent swells the PS, thus incorporating 
roughly IO5 quantum-dots in the polymer matrix of the 
bead. By vacuum drying, the pores shrink to irreversi- 
bly capture the QDs. 
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Fig. 1 Quantum-dots as optical tag of the beads: 
Three types of quantum-dots (QD578, QDhlO, 
QD653) are incorporated in beads and their lu- 
minescence spectra are recorded while being 
commonly excited by an LED 
(beak = 475 run). To optically distinguish the 
bead-tag from the signal of the high-intensity 
FluoSpheresTM [24] as assay label two optical 
filters are required. A long-pass filter (LP 570) 
selects the luminescence of the QDs to record 
the bead-tag while a band-pass filter (BP 505- 
540) exclusively transmits the signal of the 
fluorochrome as a measure of the assay result. 
PARALLEL FLUORESCENCE IMMUNOASSAY 
As an off-disk preparative step of the parallel bead- 
based FIA, each type o f  QD-encoded bead is first h n c -  
tionalized with designated capture proteins (Fig. 2). 
Next, the QD-beads representing different capture anti- 
bodies are mixed, suspended in a buffer solution, and 
loaded into the inlet reservoir of the disk (material: 
Cyclic Olefin Copolymer, COC). The disk also com- 
prises a detection chamber and an outlet drain 
(Fig. 3 - A). 
The liquid is then transported by the centrifugal force F ,  
into the detection chamber. Here, the outlet drain of the 
detection chamber establishes a geometrical barrier to 
thc beads as the depth of the chamber do,, is smaller 
than the bead diameter (i.e., do,, = 90 pm = 0.6 . dkad) 
(Fig. 3 -B). On the other hand, the depth of the 
detection chamber a,,, = 180 F]-m is chosen only slightly 
larger than dbead to aggregate a statistically distributed 
monolayer in the detection chamber. This configuration 
allows a direct optical access to all aggregated beads for 
a CCD camera mounted in a top view position of 
[211[221. 
The subsequent on-disk fluorescence immunoassay 
(FIA) is implemented by a custom-made spinning 
protocol Nt) controlling the flow rates and the incuba- 
tion times at high accuracy. After the delivery of the 
sample and washing, the FluoSpheresTM labelled, 
detection antibodies [24] specifically react with the 
previously formed antibody-antigen complex. 
A Functionalization with 
capture antibody 
B Sample containing 
target antigens 
C Detection antibody 
3 Capture antibody 
Target antigen 
Detection antibody with 
fluorescent label 
Fig. 2 Concept of a fluorescence immunoassay (FIA) 
based on beads as solid-phase. (A) The beads 
are first functionalized with a certain capture 
protein and then loaded into the detection 
chamber on-disk. (B) Next, the sample con- 
taining the target antigens is transported into 
the detection chamber and the specific antigen- 
antibody complex is formed. (C) After wash- 
ing, the added detection antibodies which are 
labelled with fluorochromes specifically bind 
to these antigen-antibody complexes. 
The read-out procedure as the final step of the parallel 
FIA significantly deviates from the procedure of the 
conventional single-channeI assay (Fig. 3 ~ C). The 
fluorescence intensity has to be spatially resolved to 
allow the assignment to the type of bead in the subse- 
quent step. We first acquire an image of the bead-tag 
distribution (LP 570, Fig. 1) by illumination with a 
high-power LED (beak =475 nm) [23] and capture the 
image with a color CCD-camera [25]. With the same 
light source, the distribution of the assay-specific fluo- 
rescence intensity is recorded in a second image with a 
bandpass filter (BP 505-540, Fig. 1 ). 
READ-OUT PROCESSING ALGORITHM 
The post-processing of the first image locates the cen- 
ters and identifies the color-IDs of the QD-labelled 
beads using a Hough transform (Fig. 4) [XI. 
TRANSDUCERS’OS 
The 13th International Conference on Solid-state Sensors, Actuators and Microsystems, Seoul, Korea, June 5-9,2005 
1115 
Authorized licensed use limited to: DUBLIN CITY UNIVERSITY. Downloaded on July 12,2010 at 13:16:33 UTC from IEEE Xplore.  Restrictions apply. 
3A1.4 
The recognition of beads starts by taking the Euclidean 
distance between the vector of a pixel and reference 
vectors of a QD-type in RGB-space. This distance is 
compared to a threshold Ri and, if accepted, the current 
pixel is transformed to the Hough space of the bead 
centers for a given bead radius. Here, each pixel-value 
within the bead-radius of the current pixel is increased 
by one. The bead centers are then determined by finding 
the maxima in Hough space. Additional robustness is 
achieved by constraining the distance of neighbouring 
beads to more than the bead radius. The programmed 
routine lasts less than 15 s and displays a reliability 
better than 80 % . 
color 
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Read-out of a bead-based fluorescence immu- 
noassay (FIA) on-disk. (A) Beads as solid 
phase of the HA are loaded into the detection 
chamber of the disk where they aggregate as a 
monolayer (B) in front of a geometrical bar- 
rier. (C) After the assay is conducted, the 
beads are excited by the light of an LED [23] 
with peak wavelength hlcak. The induced light 
(Am) of the fluorochrome [24] is spectrally fil- 
tered by the emission filter to suppress the re- 
flected light of the exciting LED and then di- 
rected towards a color CCD-camera [ 2 5 ]  as de- 
tector. Note that the photographs originally 
features distinguishable colors.' 
Fig. 3 
A Color image of QD-luminescence 
Hough-space /"?, I$-) QDz 
Fig. 4 Concept of the image processing routine for a 
three-fold assay: (A) each pixcl of the QD- 
luminescence image is transferred as a vector 
into RGB-spacc and the Euclidean distance d 
to the reference vectors QDi (i = I ,  2, 3) of the 
QD-colors is measured. (B) For d < Ri, with R, 
as a color threshold, this pixel is assigned to 
QDi  and transformed to the Hough space 1261 
of the bead centers for a given bead radius. (C) 
The bead centers are then determined by find- 
ing the maxima in Hough space. (D) From the 
fluorescence image, the assay results are meas- 
ured by averaging the fluorescencc signal 
within a concentric circle to suppress signal 
overlapping. 
RESULTS 
To demonstrate the feasibility of a parallel, disk-based 
FIA with the QD-encoded beads, a dilution series is run. 
It starts from standard human serum (Paul Ehrlich Insti- 
tute) containing a known (calibrated) concentration of 
Hepatitis-A antibodies (Fig. 5). The measured curve 
clearly allows to distinguish the state of long-term pro- 
tection by Hepatitis-A vaccination (10 international 
units per ml according to the WHO regulations). 
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Fig. 5 Calibration curve of the Hepatitis A assay: the 
result clearly allows to determine the state of 
protection by Hepatitis-A vaccination accord- 
ing to the WHO regulation (limit at 10 intema- 
tional units (IU) per mi). 
CONCLUSION 
We realized a rugged optical setup assembled by con- 
ventional components which is suitable for parallelized 
fluorescence immuno-assays. Color encoding is imple- 
mented by incorporating quantum-dots into the beads 
while high-intensity FluoSpheresTM are coupled to the 
detection antibodies. We successfully demonstrated a 
Hepatitis-A assay on a miniaturized lab-on-a-disk 
platform. In contrast to complex high-end setups such 
as sequentially operating flow cytometers, our setup 
well complies with the technical and economic demands 
of diagnostic point-of-care applications. 
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